| 1 | | Fmoc-L-Thr(tBu)-AC TG | Fmoc-L-Thr(tBu)-AC TG | C34H40N2O8
| | |
| 2 | 1789706-35-9 | (3R,4R)-1-Benzyl-N,4-dimethyl-3-piperidinamine (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]succinate | (3R,4R)-1-Benzyl-N,4-dimethyl-3-piperidinamine (2R,3R)-2,3-Bis[(4-methylbenzoyl)oxy]succinate | C34H40N2O8
| | |
| 3 | 477600-71-8 | (2R,3R)-2,3-双[(4-甲基苯甲酰基)氧基]丁二酸和 (3R,4R)-N,4-二甲基-1-(苯基甲基)-3-哌啶胺的化合物 | Butanedioic acid, 2,3-bis[(4-methylbenzoyl)oxy]-, (2R,3R)-, compd. with(3R,4R)-N,4-dimethyl-1-(phenylmethyl)-3-piperidinamine (1:2) | C34H40N2O8
| 中间体;系列1;医药中间体;医药原料中间体;枸橼酸托法替尼相关中间体;化学试剂、精细化学品、医药中间体、材料中间体 | |
| 4 | | 1,2,3,4,4a,5,7,8,13,13b,14,14a-Dodecahydro-2-methoxy-3-[2-(3,4,5-trimethoxyphenyl)vinylcarbonyloxy]benz[g]indolo[2,3-a]quinolizine-1-carboxylic acid methyl ester | 1,2,3,4,4a,5,7,8,13,13b,14,14a-Dodecahydro-2-methoxy-3-[2-(3,4,5-trimethoxyphenyl)vinylcarbonyloxy]benz[g]indolo[2,3-a]quinolizine-1-carboxylic acid methyl ester | C34H40N2O8
| | |
| 5 | 1212461-21-6 | N-(3,3'-dimethoxy-4'-{[(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]hept-1-yl)carbonyl]amino}[1,1'-biphenyl]-4-yl)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxamide | N-(3,3'-dimethoxy-4'-{[(4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]hept-1-yl)carbonyl]amino}[1,1'-biphenyl]-4-yl)-4,7,7-trimethyl-3-oxo-2-oxabicyclo[2.2.1]heptane-1-carboxamide | C34H40N2O8
| | |
| 6 | 2089130-74-3 | Benzoic acid, 4-[(1R,2S)-1-(4-cyclopropylphenyl)-2-[[[(2R)-tetrahydro-2-furanyl]carbonyl]amino]propoxy]-, (3S)-1-[[(3R)-tetrahydro-5-oxo-3-furanyl]carbonyl]-3-piperidinyl ester | Benzoic acid, 4-[(1R,2S)-1-(4-cyclopropylphenyl)-2-[[[(2R)-tetrahydro-2-furanyl]carbonyl]amino]propoxy]-, (3S)-1-[[(3R)-tetrahydro-5-oxo-3-furanyl]carbonyl]-3-piperidinyl ester | C34H40N2O8
| | |